BACE1 and Alzheimer disease: Hence, in this investigation, an E-pharmacophore model was employed to analyze the crystal structures of BACE-1 with various filters that included E-pharmacophore-based virtual screening, structure-based virtual screening, binding free energy, molecular dynamics simulation, and ADME properties to identify new BACE-1 inhibitors against Alzheimer’s disease.